Stay updated on Defactinib and VS-6766 in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page.

Latest updates to the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page
- CheckyesterdayChange DetectedA site-wide NIH banner announces a website transition and says the agency is using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check8 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check15 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1, while the page continues to show a 403 error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record and navigation, with the original study content no longer visible. This change represents an access restriction rather than a new or updated content item.SummaryDifference21%

- Check56 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6 on the study record. This reflects a minor metadata update to the page rather than a change to trial details.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, signaling a new page version. The change affects only metadata and does not alter the study information displayed.SummaryDifference0.0%

Stay in the know with updates to Defactinib and VS-6766 in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page.